PRO-CEFUROXIME - 500 TABLET
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
23-09-2019
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
CEFUROXIME (CEFUROXIME AXETIL)
Inapatikana kutoka:
PRO DOC LIMITEE
ATC kanuni:
J01DC02
INN (Jina la Kimataifa):
CEFUROXIME
Kipimo:
500MG
Dawa fomu:
TABLET
Tungo:
CEFUROXIME (CEFUROXIME AXETIL) 500MG
Njia ya uendeshaji:
ORAL
Vitengo katika mfuko:
100
Dawa ya aina:
Prescription
Eneo la matibabu:
SECOND GENERATION CEPHALOSPORINS
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0122448002; AHFS:
Idhini hali ya:
CANCELLED POST MARKET
Idhini ya tarehe:
2021-05-31
Tabia za bidhaa
Page 1 of 27
PRODUCT MONOGRAPH
PR
PRO-CEFUROXIME - 500
CEFUROXIME AXETIL TABLETS, USP
500 MG CEFUROXIME / TABLET
ANTIBIOTIC
PRO DOC LTÉE
DATE OF REVISION:
2925, boul. Industriel
September 23, 2019
Laval, Quebec
H7L 3W9
CONTROL NO.: 229806
Page 2 of 27
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
............................................................... 3
SUMMARY PRODUCT INFORMATION
...............................................................................
3
INDICATIONS AND CLINICAL USE
.....................................................................................
3
CONTRAINDICATIONS
.......................................................................................................
4
WARNINGS AND PRECAUTIONS
.......................................................................................
4
ADVERSE REACTIONS
......................................................................................................
6
DRUG INTERACTIONS
.......................................................................................................
7
DOSAGE AND ADMINISTRATION
......................................................................................
8
OVERDOSAGE
....................................................................................................................
9
ACTION AND CLINICAL PHARMACOLOGY
.......................................................................
9
STORAGE AND
STABILITY.................................................................................................
9
DOSAGE FORMS, COMPOSITION AND PACKAGING
....................................................... 9
PART II: SCIENTIFIC INFORMATION
....................................................................................10
PHARMACEUTICAL INFORMATION
..................................................................................10
CLINICAL TRIALS
...............................................................................................................11
DETAILED PHARMACOLOGY
....
Soma hati kamili
